• Cabotegravir and Rilpivirine Ultra‑Long‑Acting vs Long‑Acting in Adults and Adolescents with HIV Who Are Virally Suppressed

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of Pivekimab Sunirine Combined with Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Austria France Spain
  • Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

    Recruiting

    3 1 1 1
    France Germany Italy Poland Spain
  • Durvalumab plus drug combination as total neoadjuvant therapy for patients with resectable gastroesophageal adenocarcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany Spain
  • Phase 2 Neoadjuvant Study of Amivantamab with Lazertinib in Resectable EGFR‑Mutated Non‑Small Cell Lung Cancer Patients

    Recruiting

    2 1 1
    Investigated Drugs:
    Spain
  • Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

    Recruiting

    3 1 1 1
    France Germany Italy The Netherlands Poland Spain
  • Switching to Lenacapavir-based drug combination vs cabotegravir-based drug combination in virologically suppressed adults with HIV-1

    Recruiting

    3 1 1 1
    Investigated Diseases:
    France Germany Italy The Netherlands Poland Spain
  • Cevostamab plus pomalidomide and dexamethasone in patients with multiple myeloma previously treated with BCMA‑targeted CAR T‑cell therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

    Recruiting

    2 1
    Investigated Diseases:
    Czechia Italy Poland
  • Triple vs dual therapy with rosuvastatin, ezetimibe and bempedoic acid in patients with atherosclerotic heart disease and high cholesterol undergoing revascularisation

    Recruiting

    3 1 1 1
    Austria Germany

powered by